Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from MarketBeat

Dividend Growth or High Yield: The Income Investor's Bet

Compare dividend growth and high-yield ETF strategies to see which may perform best as inflation and Federal Reserve policy shape markets in 2026.

MarketBeat

Terrestrial Energy Q1 Earnings Call Highlights

Terrestrial Energy (NASDAQ:IMSR) said it advanced engineering, regulatory, supply chain and commercial milestones in the first quarter of 2026, as management emphasized rising electricity demand from artificial intelligence infrastructure, manufacturing reshoring and broader electrification as key d

MarketBeat

Innoviz Technologies Q1 Earnings Call Highlights

Innoviz Technologies (NASDAQ:INVZ) reported first-quarter 2026 revenue of $7.1 million and reiterated its full-year revenue outlook, while emphasizing new momentum in defense, homeland security and autonomous vehicle programs. Chief Executive Officer and Co-Founder Omer Keilaf said some non-recurri

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

AxoGen Says Nerve Repair Strategy Intact as Reimbursement Wins Gather Steam

AxoGen (NASDAQ:AXGN) President and CEO Michael Dale said the company’s growth strategy remains centered on developing the market for peripheral nerve repair, while recent reimbursement wins are expected to be positive but have not yet been quantified. Speaking during a company event, Dale said he w

MarketBeat

Ideal Power Q1 Earnings Call Highlights

Ideal Power (NASDAQ:IPWR) reported no first-quarter revenue and a wider net loss, while management emphasized growing commercial activity for its B-TRAN semiconductor technology across AI data centers, energy infrastructure, industrial systems and automotive applications. President and Chief Execut

MarketBeat

Adherex Technologies Q1 Earnings Call Highlights

Adherex Technologies (NASDAQ:FENC) executives said Fennec Pharmaceuticals entered 2026 with stronger commercial momentum for PEDMARK, reporting higher first-quarter sales, positive operating cash flow and early signs that recent sales force investments are increasing demand. On the company’s first-

MarketBeat

Fermi Q1 Earnings Call Highlights

Fermi (NASDAQ:FRMI) executives used the company’s first-quarter 2026 earnings call to outline a reset of its leadership structure, reaffirm the commercial rationale for its Project Matador power campus and detail a 90-day operating plan centered on signing a binding tenant agreement. Chairman Mariu

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

EquipmentShare.com Q1 Earnings Call Highlights

EquipmentShare.com (NASDAQ:EQPT) reported a strong first quarter of fiscal 2026 and raised its full-year outlook, citing continued demand from large contractors, growth in its rental locations and customer adoption of its T3 technology platform. Founder and Chief Executive Officer Jabbok Schlacks s

MarketBeat

DeFi Development Q1 Earnings Call Highlights

Executives at DeFi Development (NASDAQ:DFDV) used the company’s Q1 2026 earnings call to reaffirm that its central strategy remains building leveraged exposure to Solana, while also outlining how partnerships, capital allocation and ecosystem initiatives are intended to support growth in SOL per sha

MarketBeat

Palantir's Critics Are "Right"—But They're Also Still Wrong

Palantir stock pulled back after earnings, but PLTR’s explosive revenue growth and rising analyst targets suggest the bull case remains intact

MarketBeat

A New Focus for GoPro: Is a Takeover in the Frame?

GoPro's recent strategic review and pivot to professional markets signal a potential M&A opportunity for investors as the company seeks a buyout.

MarketBeat

Canadian Solar Q1 Earnings Call Highlights

Canadian Solar (NASDAQ:CSIQ) reported first-quarter 2026 revenue at the high end of its forecast and a stronger-than-expected gross margin, helped by tariff refund accruals, while the company still posted a net loss amid higher operating costs, foreign exchange losses and tax expense accruals. Exec

MarketBeat

CorMedix Q1 Earnings Call Highlights

CorMedix (NASDAQ:CRMD) reported sharply higher first-quarter 2026 revenue and profit, driven by continued adoption of DefenCath and the addition of products from its Melinta acquisition, while management raised its full-year financial outlook and outlined key pipeline developments. Chairman and Chi

MarketBeat

Cellebrite DI Q1 Earnings Call Highlights

Cellebrite DI (NASDAQ:CLBT) reported first-quarter 2026 results that management said met or exceeded the high end of its guidance for annual recurring revenue and adjusted EBITDA, while executives highlighted a wave of new product launches centered on artificial intelligence, cloud-based case manage

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Bitdeer Technologies Group Q1 Earnings Call Highlights

Bitdeer Technologies Group (NASDAQ:BTDR) reported sharply higher first-quarter revenue as its Bitcoin mining output expanded, while management emphasized a broader push into AI cloud services and large-scale data center colocation. On the company’s first-quarter 2026 earnings call, Chief Strategy O

MarketBeat

Autolus Therapeutics Q1 Earnings Call Highlights

Autolus Therapeutics (NASDAQ:AUTL) reported higher first-quarter 2026 product revenue and said its commercial launch of AUCATZYL is gaining traction in the U.S. and U.K., while reiterating full-year revenue guidance for the cell therapy. Chief Executive Officer Dr. Christian Itin said the company h

MarketBeat

BioHarvest Sciences Q1 Earnings Call Highlights

BioHarvest Sciences (NASDAQ:BHST) reported higher first-quarter revenue and reiterated its 2026 outlook as management detailed a broader reorganization around two business lines: its direct-to-consumer VINIA products business and its contract development and manufacturing organization, or CDMO, plat

MarketBeat

Aquestive Therapeutics Q1 Earnings Call Highlights

Aquestive Therapeutics (NASDAQ:AQST) said it remains on track to resubmit its new drug application for Anaphylm, its epinephrine sublingual film for severe allergic reactions, in the third quarter of 2026, while reporting higher first-quarter revenue and a narrower net loss. On the company’s first-

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Aebi Schmidt Q1 Earnings Call Highlights

Aebi Schmidt (NASDAQ:AEBI) reported higher first-quarter 2026 order intake, sales and profitability, with management pointing to strong demand in Europe and the rest of the world, improving walk-in van activity in North America and a record backlog that supports its full-year outlook. The company s

MarketBeat

Chime Finally Turns Profitable—But Risks Remain

Chime Financial delivered its first profitable quarter as revenue growth, margin expansion, and loan growth strengthened the fintech’s future prospects.

MarketBeat

eVTOL Investing: Ditch the Taxi, Buy the Blueprint

As the eVTOL sector moves from concept to reality, the focus shifts to capital-efficient business models and the de-risked path to commercialization.

MarketBeat

Resideo Technologies Q1 Earnings Call Highlights

Resideo Technologies (NYSE:REZI) reported first-quarter 2026 results above its outlook ranges and reaffirmed its full-year guidance, as executives cited solid execution across both its Products and Solutions and ADI Global Distribution businesses despite inflationary pressures and soft end markets.

MarketBeat

Reinsurance Group of America Q1 Earnings Call Highlights

Reinsurance Group of America (NYSE:RGA) reported a strong first quarter of 2026, with management pointing to broad-based earnings strength across regions, favorable claims experience and continued capital deployment into new business opportunities. On the company’s earnings call, President and Chie

MarketBeat

AeroVironment CEO Says Drone Warfare Shift Is ‘Our Moment’ as Defense Demand Builds

AeroVironment (NASDAQ:AVAV) Chairman, President and CEO Wahid Nawabi said accelerating global security threats are reshaping defense priorities toward drones, loitering munitions and counter-unmanned aircraft systems, areas where he said the company is well positioned. Speaking at a Bank of America

MarketBeat

RPC Q1 Earnings Call Highlights

RPC (NYSE:RES) reported higher first-quarter 2026 revenue as activity improved across most service lines despite winter storms early in the period, while profitability was pressured by job mix, fuel costs and working capital needs. President and CEO Ben M. Palmer said demand strengthened as the qua

1 … 41 42 43 44

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.